Trial intelligence / Profile preview

Pharmacokinetics of ertapenem and meropenem in obese surgical patients

2010-024094-39Phase 4Completed

Sponsor
Ulm University
Start
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ertapenem and meropenem (2 cohorts), sponsored by Ulm University. Primary endpoints: Free tissue kinetics of ertapenem in adipose tissue and intraperitoneal fluid, Free tissue kinetics of meropenem in adipose tissue and intraperitoneal fluid and 1 more. Started Jun 2011; status: completed.

02

Drugs

ertapenemmeropenem

Beyond the preview

Go deeper on 2010-024094-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024094-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call